Top NYSEMKT Stocks This is a current list of the top 6 companies by market capitalization on the NYSE Market Stock Exchange (NYSEMKT). Market Cap Average Analyst Rating Price Target Upside Sort By CompanySectorCurrent PriceP/E RatioMarket CapConsensus Analyst RatingConsensus Price TargetSILVSilverCrest MetalsBasic Materials$9.84-2.4%16.97$1.47 billionBuy(Score: 3.00)$7.50(-23.8% Downside)MMXMaverix MetalsBasic Materials$5.00+2.9%62.51$736.90 millionN/A(Score: 0.00)N/AGIGGigCapital4Unclassified$10.05+0.2%0.00$335.00 millionN/A(Score: 0.00)N/AMTAMetalla Royalty & StreamingBasic Materials$2.71-1.5%-33.88$249.54 millionBuy(Score: 3.25)$4.50(66.1% Upside)IBIOiBioMedical$2.83-0.4%0.00$25.89 millionN/A(Score: 0.00)N/APHGEBiomXMedical$0.75+1.5%-1.00$13.95 millionBuy(Score: 3.00)$22.50(2,900.0% Upside)(Last Updated: 1/20/2025) More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD: Loop Capital's Buy Rating Reinforces Investor Confidence Momentum Is Building for Qualcomm to Have a Strong Run in 2025 TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises Uber’s NVIDIA Deal and Buybacks Signal Major Upside Bank Stocks Are on Fire; Here’s Where the Action Is Smoking Hot Buffett’s Sale of BAC Stock: A Smart Move or Missed Opportunity? Micron Technology: Riding the AI Wave to Long-Term Growth Vertex's Pain Drug: Big Pharma's Next Major Success? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
